Results 1 to 10 of about 7,240 (114)

The Anti-Aggregative Potential of Resolvin E1 on Human Platelets

open access: yesMolecules, 2023
Resolvin E1 is a metabolite of eicosapentaenoic acid (EPA) which is one of the omega-3 polyunsaturated fatty acids (omega-3 PUFAs). The antiplatelet properties of omega-3 PUFAs are well known, but the effect of resolvin E1 on platelets via the collagen ...
Patrycja Szymańska   +2 more
exaly   +3 more sources

Does resolvin D2 reflect cognitive impairment in older adults? A clinical and biomarker analysis [PDF]

open access: yesBMC Geriatrics
Background Alzheimer’s disease is a progressive neurodegenerative disorder with an unclear etiology, in which inflammation and impaired resolution pathways may play a role.
Serap Boz   +12 more
doaj   +2 more sources

Protective Effect of Resolvin D1, D2, and Their Methyl Esters on Oxidative Stress and Hyaluronidase—Induced Hyaluronic Acid Degradation [PDF]

open access: yesAntioxidants
Hyaluronic acid (HA) injections are commonly employed in the management of osteoarthritis (OA), yet their therapeutic benefits are often limited by oxidative degradation and enzymatic breakdown within the joint.
Zahra Kariminezhad   +4 more
doaj   +2 more sources

Resolvin E3 attenuates lipopolysaccharide-induced depression-like behavior in mice

open access: yesJournal of Pharmacological Sciences, 2018
Eicosapentaenoic acid (EPA)-derived resolvin E1 (RvE1) and E2 (RvE2) have antidepressant effects. Here, we investigated the antidepressant effects of resolvin E3 (RvE3) in a mouse model of lipopolysaccharide (LPS)-induced depression. We observed that LPS
Satoshi Shuto   +2 more
exaly   +3 more sources

Evaluation of the Effects of Lipoxin A4 and Resolvin D1 on the Severity of Transient Tachypnea of the Newborn: A Prospective Study [PDF]

open access: yesChildren
Objective: Transient tachypnea of the newborn (TTN) is a common condition observed in neonates. Since its management often requires intensive care and leads to maternal–infant separation, it is a major source of parental concern.
Emrah Çığrı   +7 more
doaj   +2 more sources

Immunological response and tissue loss in a rodent model of chronic traumatic brain injury treated with resolvin [PDF]

open access: yesJournal of Inflammation
Background Traumatic brain injury (TBI) triggers neuroinflammation both acutely and chronically, the latter which might be involved in neurodegenerative disorders.
Olivia Kiwanuka   +3 more
doaj   +2 more sources

Resolvin D1 attenuates sepsis induced acute kidney injury targeting mitochondria and NF-κB signaling pathway

open access: yesHeliyon, 2022
Background: Acute kidney injury is a highly common and multifactorial renal disease resulting in significant morbidity and mortality, especially sepsis-induced acute kidney injury.
Liya Wang   +9 more
doaj   +1 more source

Protective role of resolvin D1, a pro-resolving lipid mediator, in nonsteroidal anti-inflammatory drug-induced small intestinal damage.

open access: yesPLoS ONE, 2021
Resolvin D1, a specialized pro-resolving lipid mediator produced from docosahexaenoic acid by 15- and 5-lipoxygenase, exerts anti-inflammatory effects driving to the resolution of inflammation.
Takuya Kuzumoto   +13 more
doaj   +1 more source

Resolvin E1 Regulates Th17 Function and T Cell Activation

open access: yesFrontiers in Immunology, 2021
Resolvin E1 (RvE1) is a specialized pro-resolving lipid mediator derived from eicosapentaenoic acid and plays a critical role in resolving inflammation and tissue homeostasis. Th17 cells are a distinct group of T helper (Th) cells with tissue-destructive
Fatma Oner   +10 more
doaj   +1 more source

Omega 3 Fatty Acid and Skin Diseases

open access: yesFrontiers in Immunology, 2021
Humans are exposed to various external environmental factors. Food intake is one of the most influential factors impacting daily lifestyle. Among nutrients obtained from foods, omega-3 polyunsaturated fatty acids (PUFAs) have various beneficial effects ...
Yu Sawada   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy